The Cigna Group Net Assets
The Cigna Group net assets. Based on the latest financial reports, The Cigna Group (CI) has net assets worth $43.72 Billion USD as of September 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($157.64 Billion) and total liabilities ($113.92 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore CI net assets growth trend to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $43.72 Billion |
| % of Total Assets | 27.73% |
| Annual Growth Rate | 6.22% |
| 5-Year Change | -11.25% |
| 10-Year Change | 203.76% |
| Growth Volatility | 33.67 |
Net Assets of The Cigna Group (1985–2025)
Net assets of The Cigna Group from 1985 to 2025. This chart illustrates how The Cigna Group's net assets have evolved over time, based on quarterly financial data. See CI equity to assets ratio to measure how much of total assets are equity-financed.
Annual Net Assets for The Cigna Group (1985–2025)
The table below shows the annual net assets of The Cigna Group from 1985 to 2025. For live market cap and overall valuation, see CI market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $41.87 Billion | +1.53% |
| 2024-12-31 | $41.24 Billion | -11.02% |
| 2023-12-31 | $46.35 Billion | +3.22% |
| 2022-12-31 | $44.90 Billion | -4.83% |
| 2021-12-31 | $47.18 Billion | -6.35% |
| 2020-12-31 | $50.39 Billion | +11.03% |
| 2019-12-31 | $45.38 Billion | +10.49% |
| 2018-12-31 | $41.07 Billion | +197.84% |
| 2017-12-31 | $13.79 Billion | +0.04% |
| 2016-12-31 | $13.79 Billion | +13.80% |
| 2015-12-31 | $12.11 Billion | +11.61% |
| 2014-12-31 | $10.85 Billion | +1.65% |
| 2013-12-31 | $10.68 Billion | +8.03% |
| 2012-12-31 | $9.88 Billion | +18.44% |
| 2011-12-31 | $8.34 Billion | +25.23% |
| 2010-12-31 | $6.66 Billion | +22.73% |
| 2009-12-31 | $5.43 Billion | +51.14% |
| 2008-12-31 | $3.59 Billion | -24.35% |
| 2007-12-31 | $4.75 Billion | +9.65% |
| 2006-12-31 | $4.33 Billion | -19.22% |
| 2005-12-31 | $5.36 Billion | +3.02% |
| 2004-12-31 | $5.20 Billion | +15.14% |
| 2003-12-31 | $4.52 Billion | +16.86% |
| 2002-12-31 | $3.87 Billion | -23.50% |
| 2001-12-31 | $5.05 Billion | -6.61% |
| 2000-12-31 | $5.41 Billion | -11.97% |
| 1999-12-31 | $6.15 Billion | -25.71% |
| 1998-12-31 | $8.28 Billion | +4.35% |
| 1997-12-31 | $7.93 Billion | +10.04% |
| 1996-12-31 | $7.21 Billion | +0.71% |
| 1995-12-31 | $7.16 Billion | +23.16% |
| 1994-12-31 | $5.81 Billion | -11.62% |
| 1993-12-31 | $6.58 Billion | +14.47% |
| 1992-12-31 | $5.74 Billion | -2.03% |
| 1991-12-31 | $5.86 Billion | +11.85% |
| 1990-12-31 | $5.24 Billion | -5.04% |
| 1989-12-31 | $5.52 Billion | +5.39% |
| 1988-12-31 | $5.24 Billion | +5.32% |
| 1987-12-31 | $4.97 Billion | +7.52% |
| 1986-12-31 | $4.62 Billion | +23.20% |
| 1985-12-31 | $3.75 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to The Cigna Group's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2414.8% over the analyzed period, indicating profitable operations and earnings retention.
The Cigna Group Net Assets Breakdown (December 2025)
The Cigna Group net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $47.87 Billion | 114.75% |
| Common Stock | $4.00 Million | 0.01% |
| Other Comprehensive Income | $-2.81 Billion | -6.73% |
| Total Equity | $41.71 Billion | 100.00% |
The Cigna Group Competitors by Market Cap
The table below lists competitors of The Cigna Group ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ecolab Inc
NYSE:ECL
|
$77.44 Billion |
|
General Motors Company
NYSE:GM
|
$77.78 Billion |
|
Vertiv Holdings Co
NYSE:VRT
|
$77.81 Billion |
|
Lloyds Banking Group plc
MX:LYGN
|
$78.00 Billion |
|
Republic Services Inc
NYSE:RSG
|
$77.07 Billion |
|
BAE SYSTEMS ADR/4 LS-025
F:BSPA
|
$76.97 Billion |
|
Shandong Zhongji Electrical Equipment Co Ltd
SHE:300308
|
$76.08 Billion |
|
Nan Ya Plastics Corp
TW:1303
|
$75.96 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in The Cigna Group's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 41,033,000,000 to 41,713,000,000, a change of 680,000,000 (1.7%).
- Net income of 5,957,000,000 contributed positively to equity growth.
- Dividend payments of 1,611,000,000 reduced retained earnings.
- Share repurchases of 3,621,000,000 reduced equity.
- New share issuances of 203,000,000 increased equity.
- Other comprehensive income decreased equity by 465,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $5.96 Billion | +14.28% |
| Dividends Paid | $1.61 Billion | -3.86% |
| Share Repurchases | $3.62 Billion | -8.68% |
| Share Issuances | $203.00 Million | +0.49% |
| Other Comprehensive Income | $-465.00 Million | -1.11% |
| Other Changes | $217.00 Million | +0.52% |
| Total Change | $- | 1.66% |
Book Value vs Market Value Analysis
This analysis compares The Cigna Group's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.89x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 48.93x to 1.89x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $6.07 | $297.00 | x |
| 1986-12-31 | $6.73 | $297.00 | x |
| 1987-12-31 | $6.97 | $297.00 | x |
| 1988-12-31 | $7.39 | $297.00 | x |
| 1989-12-31 | $7.80 | $297.00 | x |
| 1990-12-31 | $7.67 | $297.00 | x |
| 1991-12-31 | $9.09 | $297.00 | x |
| 1992-12-31 | $8.92 | $297.00 | x |
| 1993-12-31 | $10.20 | $297.00 | x |
| 1994-12-31 | $8.90 | $297.00 | x |
| 1995-12-31 | $10.78 | $297.00 | x |
| 1996-12-31 | $10.50 | $297.00 | x |
| 1997-12-31 | $11.87 | $297.00 | x |
| 1998-12-31 | $12.92 | $297.00 | x |
| 1999-12-31 | $10.39 | $297.00 | x |
| 2000-12-31 | $11.15 | $297.00 | x |
| 2001-12-31 | $11.18 | $297.00 | x |
| 2002-12-31 | $9.14 | $297.00 | x |
| 2003-12-31 | $10.73 | $297.00 | x |
| 2004-12-31 | $12.58 | $297.00 | x |
| 2005-12-31 | $13.77 | $297.00 | x |
| 2006-12-31 | $12.86 | $297.00 | x |
| 2007-12-31 | $16.77 | $297.00 | x |
| 2008-12-31 | $12.88 | $297.00 | x |
| 2009-12-31 | $19.67 | $297.00 | x |
| 2010-12-31 | $24.14 | $297.00 | x |
| 2011-12-31 | $30.42 | $297.00 | x |
| 2012-12-31 | $33.74 | $297.00 | x |
| 2013-12-31 | $37.12 | $297.00 | x |
| 2014-12-31 | $40.11 | $297.00 | x |
| 2015-12-31 | $46.18 | $297.00 | x |
| 2016-12-31 | $52.85 | $297.00 | x |
| 2017-12-31 | $56.30 | $297.00 | x |
| 2018-12-31 | $166.34 | $297.00 | x |
| 2019-12-31 | $119.37 | $297.00 | x |
| 2020-12-31 | $136.60 | $297.00 | x |
| 2021-12-31 | $138.17 | $297.00 | x |
| 2022-12-31 | $143.33 | $297.00 | x |
| 2023-12-31 | $155.69 | $297.00 | x |
| 2024-12-31 | $144.88 | $297.00 | x |
| 2025-12-31 | $156.85 | $297.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently The Cigna Group utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.28%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.17%
- • Asset Turnover: 1.74x
- • Equity Multiplier: 3.79x
- Recent ROE (14.28%) is above the historical average (13.05%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | -22.77% | 0.00% | 0.00x | 11.92x | $-1.23 Billion |
| 1986 | 11.57% | 0.00% | 0.00x | 10.81x | $72.40 Million |
| 1987 | 13.79% | 0.00% | 0.00x | 10.76x | $188.30 Million |
| 1988 | 9.02% | 0.00% | 0.00x | 10.66x | $-51.56 Million |
| 1989 | 10.18% | 4.89% | 0.20x | 10.47x | $10.00 Million |
| 1990 | 6.30% | 2.36% | 0.22x | 12.15x | $-194.20 Million |
| 1991 | 7.66% | 3.14% | 0.21x | 11.38x | $-137.30 Million |
| 1992 | 5.41% | 2.23% | 0.20x | 12.16x | $-263.40 Million |
| 1993 | 3.56% | 1.71% | 0.16x | 12.92x | $-423.50 Million |
| 1994 | 9.53% | 3.01% | 0.21x | 14.82x | $-27.10 Million |
| 1995 | 2.95% | 1.11% | 0.20x | 13.40x | $-504.70 Million |
| 1996 | 14.65% | 5.57% | 0.19x | 13.73x | $335.20 Million |
| 1997 | 13.69% | 9.22% | 0.11x | 13.64x | $292.80 Million |
| 1998 | 15.61% | 7.32% | 0.15x | 13.85x | $464.30 Million |
| 1999 | 28.85% | 9.47% | 0.20x | 15.50x | $1.16 Billion |
| 2000 | 17.46% | 4.84% | 0.21x | 17.57x | $403.70 Million |
| 2001 | 18.58% | 5.05% | 0.20x | 18.12x | $433.50 Million |
| 2002 | -11.56% | -2.31% | 0.22x | 23.00x | $-833.70 Million |
| 2003 | 13.99% | 3.36% | 0.21x | 20.13x | $180.10 Million |
| 2004 | 27.64% | 7.91% | 0.22x | 15.58x | $917.70 Million |
| 2005 | 30.32% | 9.74% | 0.37x | 8.37x | $1.09 Billion |
| 2006 | 26.67% | 6.98% | 0.39x | 9.79x | $722.00 Million |
| 2007 | 23.48% | 6.33% | 0.44x | 8.44x | $640.20 Million |
| 2008 | 8.13% | 1.53% | 0.46x | 11.53x | $-67.20 Million |
| 2009 | 24.04% | 7.07% | 0.43x | 7.94x | $760.30 Million |
| 2010 | 19.25% | 6.07% | 0.46x | 6.87x | $614.50 Million |
| 2011 | 15.10% | 5.82% | 0.42x | 6.12x | $425.60 Million |
| 2012 | 16.61% | 5.57% | 0.57x | 5.22x | $646.10 Million |
| 2013 | 13.97% | 4.56% | 0.60x | 5.14x | $419.30 Million |
| 2014 | 19.51% | 6.02% | 0.62x | 5.19x | $1.02 Billion |
| 2015 | 17.40% | 5.53% | 0.66x | 4.74x | $890.50 Million |
| 2016 | 13.60% | 4.69% | 0.67x | 4.33x | $494.70 Million |
| 2017 | 16.29% | 5.35% | 0.68x | 4.50x | $863.50 Million |
| 2018 | 6.43% | 5.42% | 0.32x | 3.73x | $-1.47 Billion |
| 2019 | 11.26% | 3.32% | 0.99x | 3.44x | $570.20 Million |
| 2020 | 16.81% | 5.27% | 1.03x | 3.09x | $3.43 Billion |
| 2021 | 11.40% | 3.08% | 1.12x | 3.29x | $658.80 Million |
| 2022 | 14.94% | 3.71% | 1.25x | 3.21x | $2.22 Billion |
| 2023 | 11.17% | 2.64% | 1.28x | 3.30x | $541.70 Million |
| 2024 | 8.37% | 1.39% | 1.59x | 3.80x | $-669.30 Million |
| 2025 | 14.28% | 2.17% | 1.74x | 3.79x | $1.79 Billion |
Industry Comparison
This section compares The Cigna Group's net assets metrics with peer companies in the Healthcare Plans industry.
Industry Context
- Industry: Healthcare Plans
- Average net assets among peers: $8,709,437,280
- Average return on equity (ROE) among peers: -0.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| The Cigna Group (CI) | $43.72 Billion | -22.77% | 2.61x | $77.36 Billion |
| Alignment Healthcare LLC (ALHC) | $30.61 Million | -74.89% | 10.06x | $1.54 Billion |
| Clover Health Investments Corp (CLOV) | $-613.19 Million | 0.00% | 0.00x | $2.18 Billion |
| Centene Corp (CNC) | $103.06 Million | 24.86% | 1.04x | $29.04 Billion |
| CVS Health Corp (CVS) | $34.57 Billion | 9.29% | 0.76x | $101.04 Billion |
| Elevance Health Inc (ELV) | $33.20 Billion | 13.77% | 1.66x | $91.81 Billion |
| Humana Inc (HUM) | $9.84 Billion | 24.87% | 1.71x | $53.29 Billion |
| Molina Healthcare Inc (MOH) | $1.65 Billion | 0.49% | 3.52x | $10.89 Billion |
| Marpai Inc (MRAI) | $-13.44 Million | 0.00% | 0.00x | $55.64 Million |
| NeueHealth Inc (NEUE) | $-386.11 Million | 0.00% | 0.00x | $60.94 Million |
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network … Read more